Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
| ▸ | MAPK14 | Q16539 | 6/20 | 0.32 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | BDKRB1 | P46663 | 1/20 | 0.30 |
| ▸ | F2 | P00734 | 1/20 | 0.30 |
| ▸ | F11 | P03951 | 1/20 | 0.30 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.30 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.30 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20157904 | 0.89 | CXCR2 (0.35) | CXCR2 | |
| SCHEMBL20158134 | 0.81 | SRD5A2 (0.35) | HTT | |
| SCHEMBL21352255 | 0.81 | CES2 (0.34) | CES2CES1MAPK14CXCR2HTT | |
| SCHEMBL20157797 | 0.81 | CXCR2 (0.36) | CES2CES1MAPK14CXCR2HTT | |
| SCHEMBL21362081 | 0.78 | CXCR2 (0.38) | CXCR2F2F11PRSS1PRSS2 | |
| SCHEMBL20157794 | 0.72 | KLKB1 (0.34) | KMT2A | |
| SCHEMBL21352090 | 0.71 | PYGL (0.34) | MAPK14CXCR2 | |
| SCHEMBL21362596 | 0.70 | LPL (0.42) | CXCR2 | |
| SCHEMBL20157420 | 0.69 | CXCR2 (0.36) | CXCR2 | |
| SCHEMBL20157831 | 0.69 | CXCR2 (0.40) | CXCR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3539960-A1 | NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | Luoxin Pharmaceutical (Shanghai) Co., Ltd. (CN) | 2019-09-18 | — | — | EP | disclosed |